• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].

作者信息

Yang Zhiguang, Lin Xingyu, Zhang Peng, Liu Yunpeng, Liu Zihao, Qian Benxin, Liu Xing, Shao Guoguang

机构信息

Department of Thoracic Surgery, The First Hospital of Jilin University, #71 Xinmin Street, Chaoyang District, Changchun 130021, Jilin, China.

Department of Thoracic Surgery, The First Hospital of Jilin University, #71 Xinmin Street, Chaoyang District, Changchun 130021, Jilin, China.

出版信息

Biomed Pharmacother. 2023 Apr;160:114278. doi: 10.1016/j.biopha.2023.114278. Epub 2023 Jan 31.

DOI:10.1016/j.biopha.2023.114278
PMID:36732173
Abstract
摘要

相似文献

1
Retraction notice to "Long non-coding RNA LINC00525 promotes the non-small cell lung cancer progression by targeting miR-338-3p/IRS2 axis" [Biomed. Pharmacother. 124 (2020) 109858].撤回通知：“长链非编码RNA LINC00525通过靶向miR-338-3p/IRS2轴促进非小细胞肺癌进展”[《生物医学与药物治疗》124卷（2020年）109858]
Biomed Pharmacother. 2023 Apr;160:114278. doi: 10.1016/j.biopha.2023.114278. Epub 2023 Jan 31.
2
Retraction notice to "Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p" [Biomed. Pharmacother. 108 (2018) 1022-1028].
Biomed Pharmacother. 2022 Sep;153:113354. doi: 10.1016/j.biopha.2022.113354. Epub 2022 Jul 11.
3
Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
Biomed Pharmacother. 2023 Dec 31;169:115376. doi: 10.1016/j.biopha.2023.115376. Epub 2023 Nov 27.
4
Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression.长链非编码RNA LINC00525通过充当微小RNA-505-3p的海绵并因此提高HMGB1表达来促进脊索瘤的侵袭性表型。
Onco Targets Ther. 2020 Sep 10;13:9015-9027. doi: 10.2147/OTT.S268678. eCollection 2020.
5
Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].撤回声明：“长链非编码RNA TTN-AS1通过调节miR-139-5p/ROCK2轴促进卵巢癌肿瘤发生”[《生物医学与药物治疗》125卷（2020年）109882页]
Biomed Pharmacother. 2022 Sep;153:113356. doi: 10.1016/j.biopha.2022.113356. Epub 2022 Jul 11.
6
Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705-711].
Biomed Pharmacother. 2023 Dec;168:115377. doi: 10.1016/j.biopha.2023.115377. Epub 2023 Oct 5.
7
Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis.长链非编码RNA LINC00525通过靶向miR-507/ELK3轴促进结直肠癌的干性和化疗耐药性。
Int J Stem Cells. 2019 Jul 31;12(2):347-359. doi: 10.15283/ijsc19041.
8
Retraction notice to "Long non-coding RNA HULC interacts with miR-613 to regulate colon cancer growth and metastasis through targeting RTKN" [Biomed. Pharmacother. 109 (2019) 2035-2042].
Biomed Pharmacother. 2023 Nov;167:115370. doi: 10.1016/j.biopha.2023.115370. Epub 2023 Oct 5.
9
Retraction notice to "MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC)" [Biomed. Pharmacother. 76 (2015) 82-93].撤回声明：“MiR-1290通过靶向食管鳞状细胞癌（ESCC）中的核因子I/X（NFIX）促进癌症进展”[《生物医学与药物治疗》76（2015）82-93] 。
Biomed Pharmacother. 2024 Feb;171:116189. doi: 10.1016/j.biopha.2024.116189. Epub 2024 Jan 30.
10
Retraction notice to "miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1" [Biomed. Pharmacother. 106 (2018) 1072-1081].撤回声明：“miR-539通过靶向DCLK1增强非小细胞肺癌对顺铂的化疗敏感性”[《生物医学与药物治疗》106(2018)1072 - 1081]
Biomed Pharmacother. 2023 Jun;162:114720. doi: 10.1016/j.biopha.2023.114720. Epub 2023 Apr 20.